Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Psoriasis Treatment Market: By Drug Class: TNF Inhibitors, Interleukins, Others; By Type: Plaque Psoriasis, Psoriatic Arthritis, Others; By Route of Administration; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Psoriasis Treatment Market Outlook
The global psoriasis treatment market attained a value of about USD 21.9 billion in 2020. The market is further expected to grow at a CAGR of 9.23% during the forecast period of 2022-2027 to reach nearly USD 37.20 billion by 2026.
The Increasing Prevalence of Psoriasis Disease is Augmenting the Market Growth of Psoriasis Treatment
The global market for psoriasis treatment is being driven by increasing incidences of psoriasis due to certain genetic or environmental factors, thereby augmenting the demand for effective treatment and hence stimulating the growth of the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
According to the World Health Organisation, the reported prevalence of psoriasis in countries range from 0.09% to 11.4%, making it a serious global problem. A combination of topical and systematic therapies to reduce the effects of psoriasis is a lifelong treatment aimed at remission, has been driving the growth of the market. Thus, robust investments towards the development of advanced treatment methods to control the spread of psoriasis disease are aiding the market growth.
Psoriasis Treatment: Industry Definition and Segmentation
Psoriasis refers to a common inflammatory condition in which skin cells build up and form scales and itchy, dry patches. Treatment such as topical ointments, light therapy, and medication aims to remove scales and stop the robust growth of skin cells.
On the basis of drug class, the market can be divided into:
- TNF Inhibitors
- Interleukins
- Others
Based on type, the market can be categorised into:
- Plaque Psoriasis
- Psoriatic Arthritis
- Others
The market, based on route of administration, can be segmented into:
- Oral
- Parenteral
- Topical
On the basis of distribution channel, the market can be classified into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The EMR report looks into the regional markets of psoriasis treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Robust Research and Development (R&D) for the Development of Effective Treatments to Propel the Market Growth
The growth in the global market for psoriasis treatment is expected to be determined by the rising awareness regarding the negative impact of the disease. Since the exact reason for the psoriasis disease is unknown, robust research and development (R&D) about the cause, potential effects, and effective treatments is expected to have a significant influence over the growth of the market. In addition to this, favourable government measures such as reimbursement schemes, subsidised treatments, and other thoughtful measures are also expected to boost the market growth. Moreover, the market is further projected to grow due to the presence of an extensive distribution channel, including retail and hospital pharmacies and online channels, which aid in the easy availability of the medication. Hence, these factors are anticipated to bolster the overall market growth of psoriasis treatment.
Key Industry Players in the Global Psoriasis Treatment Market
The report presents a detailed analysis of the following key players in the global psoriasis treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
- AbbVie Inc.
- Novartis AG
- Johnson and Johnson Services, Inc.
- Pfizer Inc.
- Merc and Co., Inc.
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Type, Route of Administration, Distribution Channel, Region |
| Breakup by Drug Class | TNF Inhibitors, Interleukins, Others |
| Breakup by Type | Plaque Psoriasis, Psoriatic Arthritis, Others |
| Breakup by Route of Administration | Oral, Parenteral, Topical |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AbbVie Inc., Novartis AG, Johnson and Johnson Services, Inc., Pfizer Inc., Merc and Co., Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Psoriasis Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Psoriasis Treatment Historical Market (2017-2021)
8.3 Global Psoriasis Treatment Market Forecast (2022-2027)
8.4 Global Psoriasis Treatment Market by Drug Class
8.4.1 TNF Inhibitors
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Interleukins
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Others
8.5 Global Psoriasis Treatment Market by Type
8.5.1 Plaque Psoriasis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Psoriatic Arthritis
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Others
8.6 Global Psoriasis Treatment Market by Route of Administration
8.6.1 Oral
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Parenteral
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Topical
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.7 Global Psoriasis Treatment Market by Distribution Channel
8.7.1 Hospital Pharmacies
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Retail Pharmacies
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Online Pharmacies
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.8 Global Psoriasis Treatment Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 AbbVie Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Novartis AG
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Johnson and Johnson Services, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Pfizer Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Merc and Co., Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global Psoriasis Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Psoriasis Treatment Historical Market: Breakup by Drug Class (USD Billion), 2017-2021
3. Global Psoriasis Treatment Market Forecast: Breakup by Drug Class (USD Billion), 2022-2027
4. Global Psoriasis Treatment Historical Market: Breakup by Type (USD Billion), 2017-2021
5. Global Psoriasis Treatment Market Forecast: Breakup by Type (USD Billion), 2022-2027
6. Global Psoriasis Treatment Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
7. Global Psoriasis Treatment Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
8. Global Psoriasis Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
9. Global Psoriasis Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
10. Global Psoriasis Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Psoriasis Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Psoriasis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Psoriasis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Psoriasis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Psoriasis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Psoriasis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Psoriasis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Psoriasis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Psoriasis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Psoriasis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Psoriasis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Global Psoriasis Treatment Market Structure
Key Questions Answered in the Report
The global psoriasis treatment market attained a value of nearly USD 21.9 billion in 2020.
The market is projected to grow at a CAGR of 9.23% in the forecast period of 2022-2027.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 37.20 billion by 2026.
The increasing prevalence of psoriasis disease is augmenting the demand for an effective treatment, which is propelling the overall growth of the market.
The market is expected to be driven by the robust research and development (R&D) towards the development of an effective treatment of psoriasis.
The major regional markets for psoriasis treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The major drug classes of psoriasis treatment are TNF inhibitors and interleukins, among others.
The different types of psoriasis treatment are plaque psoriasis, and psoriatic arthritis, among others.
The market, based on route of administration, can be segmented into oral, parenteral, and topical.
The significant distribution channels of psoriasis treatment are hospital pharmacies, retail pharmacies, and online pharmacies.
The major players in the industry are AbbVie Inc., Novartis AG, Johnson and Johnson Services, Inc., Pfizer Inc., and Merc and Co., Inc., among others.
Analyst Review
The global psoriasis treatment market attained a value of about USD 21.9 billion in 2020, driven by the increasing incidences of psoriasis. Aided by conscious governmental measures, the market is expected to grow at a CAGR of 9.23% in the forecast period of 2022-2027 to reach nearly USD 37.20 billion by 2026.
EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. On the basis of drug class, the market can be divided into TNF inhibitors and interleukins, among others. Based on type, the market can be categorised into plaque psoriasis, and psoriatic arthritis, among others. The market segmentations based on route of administration include oral, parenteral, and topical. On the basis of distribution channel, the major market divisions are hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for psoriasis treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are AbbVie Inc., Novartis AG, Johnson and Johnson Services, Inc., Pfizer Inc., and Merc and Co., Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global peptide therapeutics market attained a value of 31.4 billion in 2021, driven by the increasing prevalence of cancer. Aided by the increasing clinical trials and the growing FDA approval of ...
The global nicotine replacement therapy market attained a value of more than USD 44.7 billion in 2021, driven by the growing prevalence of health-related issues associated with cigarette smoking. Aide...
The global exocrine pancreatic insufficiency treatment market attained a value of more than USD 3.6 billion in 2021, driven by rising prevalence of EPI causing disorders. Aided by robust investments i...
The global venipuncture procedure analysis market attained a value of about USD 864.2 million in 2020, driven by the presence of various blood diseases. Aided by the advancements in venipuncture proce...
The global neutropenia treatment market attained a value of about USD 13.4 billion in 2020, driven by the rise in cancer cases leading to development of novel therapies. Aided by the rising awareness ...
NEWSLETTER